Aurora Cannabis (ACB) vs Anika Therapeutics (ANIK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anika Therapeutics (ANIK) has outperformed Aurora Cannabis (ACB) over the past year, gaining 108.1% versus a loss of 27.4%. Over five years, ANIK leads with a -53.8% price change compared with -93.7% for ACB. Aurora Cannabis is the larger company by market cap ($280.5 million vs $257.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | ANIK |
|---|---|---|
| Share price | $4.43 | $19.23 |
| Market cap | $280.46M | $257.35M |
| 1-day change | -0.67% | -1.54% |
| YTD return | +4.98% | +100.10% |
| 1-year return | -27.38% | +108.12% |
| 5-year return | -93.70% | -53.84% |
| Forward P/E | — | 20.24 |
| EPS (TTM) | $-0.61 | $-0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $22.88 |
| 52-week low | $2.56 | $8.67 |
| Distance from 52-week high | -33.53% | -15.95% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | — | +19.60% |
| Average volume | 1.36M | 98.57K |
| Shares outstanding | 63.31M | 13.38M |
| Employees | 1,028 | 235 |
| Sector | Healthcare | Health Care |
| Industry | Drug Manufacturers - Specialty & Generic | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANIK has outperformed ACB by 135.5 percentage points over the past year.
- The two companies sit in different sectors: Aurora Cannabis in Healthcare and Anika Therapeutics in Health Care.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Anika Therapeutics
ANIK stock →Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.
Health Care · Medical/Dental Instruments · 235 employees
ACB vs ANIK FAQ
Which is bigger, Aurora Cannabis or Anika Therapeutics?
Aurora Cannabis (ACB) is larger, with a market capitalization of $280.46M compared with $257.35M for Anika Therapeutics (ANIK).
Which stock has performed better over the past year, ACB or ANIK?
ANIK returned +108.12% over the past 12 months, compared with -27.38% for ACB (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Anika Therapeutics in the same industry?
No. Aurora Cannabis is in the Healthcare sector, while Anika Therapeutics is in Health Care.